Health Sciences Acquisitions Corporation 2 does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or related business combination with one or more businesses. The company was incorporated in 2020 and is based in New York, New York.
IPO Year: 2020
Exchange: NASDAQ
| Date | Price Target | Rating | Analyst |
|---|
Fastest customizable press release news feed in the world
Business combination with Health Sciences Acquisitions Corporation 2, a special purpose acquisition company sponsored by an affiliate of RTW Investments, LP, completed on January 26, 2023 The combination was announced simultaneously with Orchestra's strategic collaboration with Medtronic to develop BackBeat Cardiac Neuromodulation Therapy™ as potential integrated hypertension treatment for cardiac pacemaker patients Gross proceeds from transaction and previously completed financing led by RTW and Medtronic total approximately $180 million and support cash runway into 2026 Orchestra BioMed Holdings, Inc. to commence trading on January 27 on Nasdaq Global Market under ticker symbol "OBIO"
NEW HOPE, Pa., Sept. 20, 2022 (GLOBE NEWSWIRE) -- Orchestra BioMed™, Inc., ("Orchestra BioMed" or the "Company"), a biomedical innovation company accelerating high-impact technologies to patients through risk-reward sharing partnerships with leading medical device companies, today announced the presentation of positive long-term clinical results from the MODERATO II Control Patients Crossover Extension Study of BackBeat Cardiac Neuromodulation Therapy™ ("BackBeat CNT") at the Transcatheter Cardiovascular Therapeutics (TCT) 2022 annual conference being held in Boston, MA. BackBeat CNT is a bioelectronic therapy candidate that is compatible with standard pacemakers and designed to lower bloo
Strategic collaboration with Medtronic to develop BackBeat Cardiac Neuromodulation Therapy™ as potential integrated hypertension treatment for cardiac pacemaker patients Investors in $110 million Series D financing include Medtronic and Terumo as well as lead investor RTW Investments and founding investor Perceptive Advisors Business combination with Health Sciences Acquisitions Corporation 2 (NASDAQ:HSAQ) (the "Business Combination"); upon closing, the common stock of the combined company is expected to be listed on Nasdaq under the ticker symbol "OBIO"; Business Combination is supported by $20 million in total forward purchase agreements and an up to $50 million backstop agreement
Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.
5 - Orchestra BioMed Holdings, Inc. (0001814114) (Issuer)
3 - Orchestra BioMed Holdings, Inc. (0001814114) (Issuer)
3 - Orchestra BioMed Holdings, Inc. (0001814114) (Reporting)
4 - Orchestra BioMed Holdings, Inc. (0001814114) (Issuer)
4 - Orchestra BioMed Holdings, Inc. (0001814114) (Issuer)
4 - Orchestra BioMed Holdings, Inc. (0001814114) (Issuer)
4 - Orchestra BioMed Holdings, Inc. (0001814114) (Issuer)
4 - Orchestra BioMed Holdings, Inc. (0001814114) (Issuer)
4 - Orchestra BioMed Holdings, Inc. (0001814114) (Issuer)
4 - Orchestra BioMed Holdings, Inc. (0001814114) (Issuer)
8-K - Orchestra BioMed Holdings, Inc. (0001814114) (Filer)
8-K - Orchestra BioMed Holdings, Inc. (0001814114) (Filer)
10-Q - Orchestra BioMed Holdings, Inc. (0001814114) (Filer)
8-K - Orchestra BioMed Holdings, Inc. (0001814114) (Filer)
S-1 - Orchestra BioMed Holdings, Inc. (0001814114) (Filer)
8-K - Orchestra BioMed Holdings, Inc. (0001814114) (Filer)
10-Q - Orchestra BioMed Holdings, Inc. (0001814114) (Filer)
8-K/A - Orchestra BioMed Holdings, Inc. (0001814114) (Filer)
8-K - Orchestra BioMed Holdings, Inc. (0001814114) (Filer)
8-K - Orchestra BioMed Holdings, Inc. (0001814114) (Filer)
This live feed shows all institutional transactions in real time.
SC 13G/A - Orchestra BioMed Holdings, Inc. (0001814114) (Subject)
SC 13G/A - Orchestra BioMed Holdings, Inc. (0001814114) (Subject)
SC 13G - Orchestra BioMed Holdings, Inc. (0001814114) (Subject)
SC 13G - Orchestra BioMed Holdings, Inc. (0001814114) (Filed by)
SC 13G - Orchestra BioMed Holdings, Inc. (0001814114) (Subject)
SC 13D/A - Orchestra BioMed Holdings, Inc. (0001814114) (Subject)
SC 13G - Orchestra BioMed Holdings, Inc. (0001814114) (Subject)
SC 13G - Orchestra BioMed Holdings, Inc. (0001814114) (Subject)
SC 13G - Orchestra BioMed Holdings, Inc. (0001814114) (Subject)
SC 13D/A - Orchestra BioMed Holdings, Inc. (0001814114) (Subject)